- Report
- February 2026
- 381 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 232 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 561 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 1101 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- January 2026
- 150 Pages
Global
From €4160EUR$4,750USD£3,611GBP
- Report
- January 2026
- 120 Pages
Global
From €4160EUR$4,750USD£3,611GBP
- Report
- January 2026
- 130 Pages
Global
From €4160EUR$4,750USD£3,611GBP
- Report
- May 2025
- 120 Pages
Global
From €4160EUR$4,750USD£3,611GBP
- Report
- May 2025
- 150 Pages
Global
From €4160EUR$4,750USD£3,611GBP
- Report
- January 2026
- 168 Pages
Global
From €4160EUR$4,750USD£3,611GBP
- Report
- January 2026
- 147 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- October 2025
- 145 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- June 2025
- 400 Pages
Global
From €4334EUR$4,949USD£3,762GBP
- Report
- August 2025
- 150 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- February 2026
- 381 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 386 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 282 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 481 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 217 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 272 Pages
Global
From €5124EUR$5,850USD£4,447GBP

The Bioactive Compound market is a subset of the biotechnology industry that focuses on the development and production of compounds with biological activity. These compounds are used in a variety of applications, including drug discovery, diagnostics, and therapeutics. Bioactive compounds are typically derived from natural sources, such as plants, animals, and microorganisms, and are often modified to enhance their activity. The market is driven by the increasing demand for new and improved treatments for a variety of diseases, as well as the need for more efficient and cost-effective drug discovery processes.
The Bioactive Compound market is highly competitive, with a number of companies offering a range of products and services. Major players in the market include Merck, Pfizer, Novartis, and Roche. Other notable companies include AbbVie, AstraZeneca, and GlaxoSmithKline. Show Less Read more